(Q43637283)

25 November 2017

Thalidomide dose proportionality assessment following single doses to healthy subjects (English)

1 reference

25 November 2017

0 references

Teo SK

1

1 reference

25 November 2017

Scheffler MR

2

1 reference

25 November 2017

Kook KA

3

1 reference

25 November 2017

Tracewell WG

4

1 reference

25 November 2017

Colburn WA

5

1 reference

25 November 2017

Stirling DI

6

1 reference

25 November 2017

Thomas SD

7

1 reference

25 November 2017

1 June 2001

1 reference

The Journal of Clinical Pharmacology

25 November 2017

1 reference

25 November 2017

41

1 reference

25 November 2017

662-667

1 reference

25 November 2017

6

1 reference

Thalidomide, a current teratogen in South America

25 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Pharmacokinetics and hemodynamic effects of single oral doses of thalidomide in asymptomatic human immunodeficiency virus-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Dose-dependent absorption of amoxycillin and bacampicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Thalidomide for the treatment of chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Teratogen metabolism: thalidomide activation is mediated by cytochrome P-450

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Effects of oral thalidomide on rat liver and skin microsomal P450 isozyme activities and on urinary porphyrin excretion: interaction with oral hexachlorobenzene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

Pharmacokinetics of thalidomide in an elderly prostate cancer population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010555

10.1177/00912700122010555

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference